Related Experiment Video
Updated: May 25, 2025

13:35
Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
10.3K
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot Study
Mariateresa Zicarelli1, Marta Greco1,2, Stefanos Roumeliotis3
1Department of Health Sciences, Magna-Graecia University, 88100 Catanzaro, Italy.
Medicina (Kaunas, Lithuania)
|February 26, 2025
Summary
Sarcopenia risk is high in end-stage kidney disease (ESKD) patients on peritoneal dialysis (PD). Mitochondrial peptide MOTS-c levels are altered in PD, potentially contributing to sarcopenia risk and impacting muscle performance.
Area of Science:
- Nephrology
- Gerontology
- Molecular Biology
Background:
- Sarcopenia is prevalent in end-stage kidney disease (ESKD) patients undergoing peritoneal dialysis (PD).
- MOTS-c, a mitochondrial peptide, influences muscle growth and its levels are dysregulated in ESKD.
Purpose of the Study:
- To investigate MOTS-c balance in ESKD patients on PD.
- To determine the association between MOTS-c levels and sarcopenia risk in this cohort.
Main Methods:
- Serum, urine, and dialysate MOTS-c levels were measured in 32 chronic PD patients.
- Sarcopenia risk was assessed using the SARC-F tool, anthropometry, and physical performance tests.
Main Results:
- Patients with high sarcopenia risk exhibited lower serum MOTS-c (sMOTS-c) and higher dialysate MOTS-c (dMOTS-c), indicating increased peritoneal clearance.
- sMOTS-c correlated positively with muscle performance, while dMOTS-c and the d/s MOTS-c ratio correlated negatively.
- MOTS-c demonstrated diagnostic potential, especially when combined with physical and anthropometric data, for identifying high-risk PD patients.
Conclusions:
- Chronic PD may disrupt MOTS-c balance, potentially increasing sarcopenia risk.
- Further research is needed to validate MOTS-c as a biomarker for sarcopenia risk stratification in PD patients.
Related Concept Videos
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Dialysis
249
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
249
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K

